Clinical Trials In Indianapolis

Discover hundreds of clinical trials in Indianapolis.
Search clinical trials in Indianapolis by condition or phase.

e.g. Respiratory Diseases

Indianapolis•Healthy volunteers: No

Filter results

Results: 898

A Study to Evaluate the Safety and Efficacy of a Single Dose of RABI-767 in Participants With Acute Pancreatitis

Recruiting

Phase 2

Sponsor:

Panafina, Inc.

Location:

Indianapolis, Los Angeles, Gainesville, Orlandoshow 2 more

Code:

NCT06080789

Conditions

Acute Pancreatitis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

RABI-767

The Purpose of This Study is to Evaluate the Effects of Ruxolitinib Cream on Adults With Atopic Dermatitis Experiencing Sleep Disturbance.

Recruiting

Sponsor:

Incyte Corporation

Location:

Indianapolis, Clarksville, Fountain Valley, Long Beachshow 25 more

Code:

NCT05696392

Conditions

Atopic Dermatitis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ruxolitinib cream

ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD)

Recruiting

Phase 3

Sponsor:

Stealth BioTherapeutics Inc.

Location:

Carmel, Phoenix, Sun City, Huntington Beachshow 29 more

Code:

NCT06373731

Conditions

Age Related Macular Degeneration (ARMD)

Eligibility Criteria

Sex: All

Age: 55+

Healthy Volunteers: Not accepted

Interventions

Elamipretide

Placebo

Study of Crenolanib vs Midostaurin Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed FLT3 Mutated AML

Recruiting

Phase 3

Sponsor:

Arog Pharmaceuticals, Inc.

Location:

Indianapolis, Duarte, Los Angeles, Sacramentoshow 17 more

Code:

NCT03258931

Conditions

Newly Diagnosed FLT3 Mutated AML

Eligibility Criteria

Sex: All

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Crenolanib

Midostaurin

Cytarabine

Duanorubicin

SPYRAL AFFIRM Global Study of RDN with the Symplicity Spyral RDN System in Subjects with Uncontrolled HTN

Recruiting

Sponsor:

Medtronic Vascular

Location:

Indianapolis, Birmingham, Mesa, Phoenixshow 63 more

Code:

NCT05198674

Conditions

Hypertension

Vascular Diseases

Cardiovascular Diseases

Chronic Kidney Diseases

Diabetes Mellitus

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Renal Denervation (Symplicity Spyral™)

Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation

Recruiting

Sponsor:

Abbott Medical Devices

Location:

Indianapolis, Birmingham, Phoenix, Scottsdaleshow 60 more

Code:

NCT03433274

Conditions

Mitral Regurgitation

Mitral Insufficiency

Mitral Valve Insufficiency

Cardiovascular Diseases

Valve Disease, Heart

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Tendyne Mitral Valve System

MitraClip System

Evaluating the Genetics and Immunology of Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) Syndrome and Other Tonsil Disorders

Recruiting

Sponsor:

National Institute of Allergy and Infectious Diseases (NIAID)

Location:

Indianapolis, Washington, Bethesda

Code:

NCT05656365

Conditions

Periodic Fever, Aphthous Stomatitis, Pharyngitis, And Cervical Adenitis (Pfapa)

Obstructive Sleep Apnea

Tonsillitis

Tonsil Disorder

Sleep Disordered Breathing

Eligibility Criteria

Sex: All

Age: 1 - 70+

Healthy Volunteers: Not accepted

PO vs IV Antibiotics for the Treatment of Infected Nonunion of Fractures After Fixation

Recruiting

Phase 3

Sponsor:

Major Extremity Trauma Research Consortium

Location:

Indianapolis, Baltimore, Minneapolis, New Yorkshow 7 more

Code:

NCT05699174

Conditions

Infections

Infected Wound

Nonunion of Fracture

Injury Leg

Amputation

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Standard of Care PO (oral) antibiotics

Standard of Care Intravenous (IV) antibiotics

A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

Recruiting

Phase 3

Sponsor:

Eli Lilly and Company

Location:

Indianapolis, Newburgh, Fort Wayne, Evansvilleshow 74 more

Code:

NCT04396574

Conditions

Migraine

Eligibility Criteria

Sex: All

Age: 6 - 17

Healthy Volunteers: Not accepted

Interventions

Lasmiditan

National Collaborative to Improve Care of Children With Complex Congenital Heart Disease

Recruiting

Sponsor:

Children's Hospital Medical Center, Cincinnati

Location:

Indianapolis, Birmingham, Phoenix, Little Rockshow 52 more

Code:

NCT02852031

Conditions

Hypoplastic Left Heart Syndrome (HLHS)

Eligibility Criteria

Sex: All

Age: 0 - 15

Healthy Volunteers: Not accepted

Interventions

Collaborative Learning Network

e.g. Respiratory Diseases

Indianapolis•Healthy volunteers: No

Filter results

Results: 898

A Study to Evaluate the Safety and Efficacy of a Single Dose of RABI-767 in Participants With Acute Pancreatitis

Recruiting

Phase 2

Sponsor:

Panafina, Inc.

Location:

Indianapolis, Los Angeles, Gainesville, Orlandoshow 2 more

Code:

NCT06080789

Conditions

Acute Pancreatitis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

RABI-767

The Purpose of This Study is to Evaluate the Effects of Ruxolitinib Cream on Adults With Atopic Dermatitis Experiencing Sleep Disturbance.

Recruiting

Sponsor:

Incyte Corporation

Location:

Indianapolis, Clarksville, Fountain Valley, Long Beachshow 25 more

Code:

NCT05696392

Conditions

Atopic Dermatitis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ruxolitinib cream

ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD)

Recruiting

Phase 3

Sponsor:

Stealth BioTherapeutics Inc.

Location:

Carmel, Phoenix, Sun City, Huntington Beachshow 29 more

Code:

NCT06373731

Conditions

Age Related Macular Degeneration (ARMD)

Eligibility Criteria

Sex: All

Age: 55+

Healthy Volunteers: Not accepted

Interventions

Elamipretide

Placebo

Study of Crenolanib vs Midostaurin Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed FLT3 Mutated AML

Recruiting

Phase 3

Sponsor:

Arog Pharmaceuticals, Inc.

Location:

Indianapolis, Duarte, Los Angeles, Sacramentoshow 17 more

Code:

NCT03258931

Conditions

Newly Diagnosed FLT3 Mutated AML

Eligibility Criteria

Sex: All

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Crenolanib

Midostaurin

Cytarabine

Duanorubicin

SPYRAL AFFIRM Global Study of RDN with the Symplicity Spyral RDN System in Subjects with Uncontrolled HTN

Recruiting

Sponsor:

Medtronic Vascular

Location:

Indianapolis, Birmingham, Mesa, Phoenixshow 63 more

Code:

NCT05198674

Conditions

Hypertension

Vascular Diseases

Cardiovascular Diseases

Chronic Kidney Diseases

Diabetes Mellitus

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Renal Denervation (Symplicity Spyral™)

Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation

Recruiting

Sponsor:

Abbott Medical Devices

Location:

Indianapolis, Birmingham, Phoenix, Scottsdaleshow 60 more

Code:

NCT03433274

Conditions

Mitral Regurgitation

Mitral Insufficiency

Mitral Valve Insufficiency

Cardiovascular Diseases

Valve Disease, Heart

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Tendyne Mitral Valve System

MitraClip System

Evaluating the Genetics and Immunology of Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) Syndrome and Other Tonsil Disorders

Recruiting

Sponsor:

National Institute of Allergy and Infectious Diseases (NIAID)

Location:

Indianapolis, Washington, Bethesda

Code:

NCT05656365

Conditions

Periodic Fever, Aphthous Stomatitis, Pharyngitis, And Cervical Adenitis (Pfapa)

Obstructive Sleep Apnea

Tonsillitis

Tonsil Disorder

Sleep Disordered Breathing

Eligibility Criteria

Sex: All

Age: 1 - 70+

Healthy Volunteers: Not accepted

PO vs IV Antibiotics for the Treatment of Infected Nonunion of Fractures After Fixation

Recruiting

Phase 3

Sponsor:

Major Extremity Trauma Research Consortium

Location:

Indianapolis, Baltimore, Minneapolis, New Yorkshow 7 more

Code:

NCT05699174

Conditions

Infections

Infected Wound

Nonunion of Fracture

Injury Leg

Amputation

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Standard of Care PO (oral) antibiotics

Standard of Care Intravenous (IV) antibiotics

A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

Recruiting

Phase 3

Sponsor:

Eli Lilly and Company

Location:

Indianapolis, Newburgh, Fort Wayne, Evansvilleshow 74 more

Code:

NCT04396574

Conditions

Migraine

Eligibility Criteria

Sex: All

Age: 6 - 17

Healthy Volunteers: Not accepted

Interventions

Lasmiditan

National Collaborative to Improve Care of Children With Complex Congenital Heart Disease

Recruiting

Sponsor:

Children's Hospital Medical Center, Cincinnati

Location:

Indianapolis, Birmingham, Phoenix, Little Rockshow 52 more

Code:

NCT02852031

Conditions

Hypoplastic Left Heart Syndrome (HLHS)

Eligibility Criteria

Sex: All

Age: 0 - 15

Healthy Volunteers: Not accepted

Interventions

Collaborative Learning Network